Serum tumour markers in patients with chronic kidney disease

Author： Xiaofang Y.   Yue Z.   Xialian X.   Zhibin Y.  

Publisher： Informa Healthcare

ISSN： 0036-5513

Source： Scandinavian Journal of Clinical and Laboratory Investigation, Vol.67, Iss.6, 2007-01, pp. : 661-667

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Endothelial Activation Markers in Anemic Non-Dialysis Chronic Kidney Disease Patients

By  

Nephron Clin Pract, Vol. 110, Iss. 4, 2008-10 ,pp. : c244-c250

Karger

Access to resources Recommend Favorite

Interleukin‐10 and tumour necrosis factor‐alpha serum levels in chronic Chagas disease patients

By  

PARASITE IMMUNOLOGY (ELECTRONIC), Vol. 37, Iss. 7, 2015-07 ,pp. : 376-379

John Wiley & Sons Inc

Access to resources Recommend Favorite

Increased Serum Inflammatory Markers in the Absence of Clinical and Skeletal Muscle Inflammation in Patients with Chronic Obstructive Pulmonary Disease

By  

Respiration, Vol. 78, Iss. 2, 2009-03 ,pp. : 191-196

Karger

Access to resources Recommend Favorite

Prevalence of Chronic Kidney Disease in Elderly Patients with Normal Serum Creatinine Levels Undergoing Percutaneous Coronary Interventions

By  

Gerontology, Vol. 56, Iss. 1, 2009-12 ,pp. : 51-54

Karger

Access to resources Recommend Favorite

Effect of patiromer on reducing serum potassium and preventing recurrent hyperkalaemia in patients with heart failure and chronic kidney disease on RAAS inhibitors

By  

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 17, Iss. 10, 2015-10 ,pp. : 1057-1065

John Wiley & Sons Inc

Access to resources Recommend Favorite